BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10688045)

  • 1. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue.
    Fornari D; Steven K; Hansen AB; Jepsen JV; Poulsen AL; Vibits H; Horn T
    Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
    Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
    Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
    Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
    Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hemminki K; Larsson P
    Scand J Urol Nephrol; 2003; 37(2):106-11. PubMed ID: 12745717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.
    Hoque MO; Lee J; Begum S; Yamashita K; Engles JM; Schoenberg M; Westra WH; Sidransky D
    Cancer Res; 2003 Sep; 63(18):5723-6. PubMed ID: 14522891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of loss of heterozygosity in the p53 tumor suppressor gene using a PCR-based assay.
    Ridanpää M; Anttila S; Husgafvel-Pursiainen K
    Pathol Res Pract; 1995 Jun; 191(5):399-402. PubMed ID: 7479357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
    J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
    Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
    J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.
    Schlechte HH; Sachs MD; Lenk SV; Brenner S; Rudolph BD; Loening SA
    Cancer Detect Prev; 2000; 24(1):24-32. PubMed ID: 10757120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K; Yamada Y; Okajima E; Kakizoe T; Sasaki H; Sugimura T; Terada M
    Cancer Res; 1992 Mar; 52(6):1393-8. PubMed ID: 1540947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
    Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
    Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Under-representation of bladder transitional cell tumour 9q, 11p and 14q LOH in urine and impact on molecular diagnosis.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    Anticancer Res; 2005; 25(6B):4049-52. PubMed ID: 16309198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    Anticancer Res; 2004; 24(3a):1733-6. PubMed ID: 15274348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.